Fusion Fuel Overview: Highlights of the business, recent developments, details of the QIND transaction, group targets, and NASDAQ compliance. Al Shola Gas Business Update: Overview of Al Shola’s ...

Company Reports Strong Scientific Engagement, Advances Texas Tech Discussions, and Continues Preparations for Texatron™ TestingSOUTHLAKE, Texas, June 23, 2026 (GLOBE NEWSWIRE) -- American Fusion Inc.

HAMILTON, ON and BOSTON, Oct. 12, 2023 /CNW/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision ...

Reminds Shareholders of June 8, 2026 Extraordinary General Meeting to Vote on Royal Uranium Acquisition, Preferred Shares Conversion and Proposed Name Change to Fusion Elements plc Dublin, May 27, ...

Preliminary data demonstrate FPI-2265 is active in heavily pretreated patients with progressive metastatic castration-resistant prostate cancer (mCRPC), including those who received prior ...

Following the live event, a recording of the presentation, the slides used, and the responses to the question-and-answer session will be made available on the Investor Meet Company platform. This ...

SAN CARLOS, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or “Biomea Fusion” or “the Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced ...